Regression of acquired reactive perforating collagenosis after dipeptidyl peptidase-4 inhibitor cessation

J Dermatol. 2022 Jul;49(7):e238-e240. doi: 10.1111/1346-8138.16361. Epub 2022 Mar 22.

Authors

Takuya Kawamura¹, Yosuke Mai¹, Atsushi Narahira¹, Yoshihiro Matsuno², Wataru Nishie¹, Hideyuki Ujiie¹

Affiliations

¹ Department of Dermatology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan.
² Department of Pathology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan.

PMID: 35315533
DOI: 10.1111/1346-8138.16361

No abstract available

Publication types

Letter

MeSH terms

Collagen Diseases* / drug therapy
Dipeptidyl-Peptidase IV Inhibitors* / adverse effects
Dipeptidyl-Peptidases and Tripeptidyl-Peptidases
Humans
Hypoglycemic Agents
Skin Diseases* / drug therapy
Skin Diseases* / etiology

Substances

Dipeptidyl-Peptidase IV Inhibitors
Hypoglycemic Agents
Dipeptidyl-Peptidases and Tripeptidyl-Peptidases